Results 51 to 60 of about 32,815 (188)
The Turkish Journal of Pediatrics, 2001 We report a pediatric case who developed bleomycin-induced hyperpigmentation and hypersensitivity reactions to both etoposide and vinblastine while receiving chemotherapy for germ cell tumor.
K Mutafoğlu-Uysal +2 more
doaj
A practical guide to over‐the‐counter treatments for hyperpigmentation
JEADV Clinical PracticeHyperpigmentation of the skin, defined as increased melanin in the epidermis, is a common condition associated with psychosocial impairment and decreased quality of life. Prescription options are often not covered by insurance and can be cost prohibitive.
Mustufa Jafry +2 more
doaj +1 more source
Psychodermatology of the Female: Hormones, Skin and Mental Health Across the Lifespan
JEADV Clinical Practice, EarlyView.Hormonal transitions across the female lifespan shape skin disease and psychiatric comorbidity through the brain–skin axis and Neuro‐Immuno‐Cutaneous‐Endocrine (NICE) network. This narrative review links puberty, menstruation, pregnancy, postpartum and menopause to dermatologic and psychosocial outcomes.
Sheila Sharifi +4 more
wiley +1 more source
JEADV Clinical Practice, EarlyView.Skin frailty (SF) is a common condition affecting adults aged ≥65 years. However, the lack of a validated and reliable visual scale to assess SF severity is a barrier to clinical care and research. In this study, we developed a 9‐parameter Skin Frailty Score (SFS), validated by two board‐certified dermatologists and meeting item and scale level content
Po‐Han Ho +9 more
wiley +1 more source
Tegafur-induced acral hyperpigmentation
Dermatology Reports, 2011 Tegafur is a prodrug of 5-fluorouracil (5-FU) with a similar spectrum of antitumor activity. It is used in the treatment of advanced gastrointestinal neoplasms.
Vera Teixeira +2 more
doaj +1 more source
Brentuximab Vedotin‐Induced Rash Sparing CD30‐Positive Mycosis Fungoides Lesions
JEADV Clinical Practice, EarlyView.ABSTRACT Brentuximab vedotin (BV) is an effective treatment for CD30‐positive lymphomas, including mycosis fungoides (MF). However, its use can be associated with various cutaneous adverse effects, including rashes. This case describes a 60‐year‐old male with stage IIB MF who developed a drug‐induced erythematous rash after three infusions of BV ...
Isabel Hariri +2 more
wiley +1 more source
Nail Disorders in Systemic Conditions
JEADV Clinical Practice, EarlyView.ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley +1 more source
Plants used to treat hyperpigmentation in Iranian traditional medicine: a review [PDF]
Research Journal of Pharmacognosy, 2017 Skin hyperpigmentation is characterized as increased production and accumulation of melanin, which could be aesthetically unfavorable and develops serious skin diseases.
S. Ghafari, Sh. Fahimi, Sh. Sahranavard
doaj
JEADV Clinical Practice, EarlyView.ABSTRACT Setmelanotide is a melanocortin‐4 receptor agonist approved for the treatment of rare forms of genetic obesity. Through off‐target activation of the melanocortin‐1 receptor, it may induce cutaneous pigmentation changes; however, data regarding its effects on melanocytic nevi remain limited.
Martina Cavicchi +5 more
wiley +1 more source
Lichenoid type cutaneous hyperpigmentation induced by nebivolol
Türk Kardiyoloji Derneği Arşivi, 2017 Cutaneous hyperpigmentation is a common and well-defined side effect of many drugs, such as non-steroidal anti-inflammatory drugs, beta-blockers, and tetracyclines, but to the best of our knowledge there is no case of skin discoloration related to ...
Abdullah Nabi Aslan +4 more
doaj +1 more source